Landscape Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
DM
CS
RSCM
TCM
Landscape Capital Management's LKFT Position: Q4 2018 in Review
Landscape Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018, closing a stake of 4,869 shares — an estimated $547K sold.
Landscape Capital Management first reported a position in LKFT in Q2 2015 and held it in 12 quarters. The position peaked at $1.39M in Q1 2018. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.
- Landscape Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2018 after selling out during the quarter.
- Landscape Capital Management sold 4,869 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2018, an estimated $547K.
- Landscape Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 12 quarters.
- Landscape Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.39M in Q1 2018.
- 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.
Based on Landscape Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.